nodes	percent_of_prediction	percent_of_DWPC	metapath
Trimethoprim—CYP2C9—Diclofenamide—glaucoma	0.0761	0.137	CbGbCtD
Trimethoprim—CYP2C9—Dorzolamide—glaucoma	0.0735	0.133	CbGbCtD
Trimethoprim—CYP2C9—Methazolamide—glaucoma	0.0655	0.118	CbGbCtD
Trimethoprim—CYP3A4—Pilocarpine—glaucoma	0.0564	0.102	CbGbCtD
Trimethoprim—ABCB1—Timolol—glaucoma	0.054	0.0975	CbGbCtD
Trimethoprim—ABCB1—Clonidine—glaucoma	0.0459	0.0829	CbGbCtD
Trimethoprim—CYP3A4—Brinzolamide—glaucoma	0.0442	0.0798	CbGbCtD
Trimethoprim—CYP3A4—Dorzolamide—glaucoma	0.0427	0.0771	CbGbCtD
Trimethoprim—CYP3A4—Methazolamide—glaucoma	0.0381	0.0687	CbGbCtD
Trimethoprim—CYP3A4—Acetazolamide—glaucoma	0.0304	0.0549	CbGbCtD
Trimethoprim—CYP3A4—Clonidine—glaucoma	0.0275	0.0497	CbGbCtD
Trimethoprim—DHFR—Folate Metabolism—ABCA1—glaucoma	0.000832	0.0137	CbGpPWpGaD
Trimethoprim—TYMS—Circadian rythm related genes—OPN4—glaucoma	0.000805	0.0133	CbGpPWpGaD
Trimethoprim—DHFR—Folate Metabolism—SOD1—glaucoma	0.000742	0.0122	CbGpPWpGaD
Trimethoprim—CYP3A4—Benzo(a)pyrene metabolism—CYP1B1—glaucoma	0.00068	0.0112	CbGpPWpGaD
Trimethoprim—CYP3A4—Aflatoxin B1 metabolism—GSTM1—glaucoma	0.000664	0.0109	CbGpPWpGaD
Trimethoprim—CYP2C8—Tamoxifen metabolism—CYP1B1—glaucoma	0.000643	0.0106	CbGpPWpGaD
Trimethoprim—DHFR—Folate Metabolism—MTHFR—glaucoma	0.000588	0.00968	CbGpPWpGaD
Trimethoprim—CYP2C9—Tamoxifen metabolism—CYP1B1—glaucoma	0.000523	0.00862	CbGpPWpGaD
Trimethoprim—Skin disorder—Travoprost—glaucoma	0.000484	0.00126	CcSEcCtD
Trimethoprim—Abdominal pain—Apraclonidine—glaucoma	0.000482	0.00125	CcSEcCtD
Trimethoprim—Nervous system disorder—Brinzolamide—glaucoma	0.000482	0.00125	CcSEcCtD
Trimethoprim—Rash—Latanoprost—glaucoma	0.000481	0.00125	CcSEcCtD
Trimethoprim—Agranulocytosis—Betaxolol—glaucoma	0.000481	0.00125	CcSEcCtD
Trimethoprim—Dermatitis—Latanoprost—glaucoma	0.000481	0.00125	CcSEcCtD
Trimethoprim—Dyspepsia—Acetazolamide—glaucoma	0.00048	0.00125	CcSEcCtD
Trimethoprim—Mediastinal disorder—Clonidine—glaucoma	0.000479	0.00124	CcSEcCtD
Trimethoprim—Headache—Latanoprost—glaucoma	0.000478	0.00124	CcSEcCtD
Trimethoprim—Skin disorder—Brinzolamide—glaucoma	0.000478	0.00124	CcSEcCtD
Trimethoprim—Musculoskeletal discomfort—Brimonidine—glaucoma	0.000477	0.00124	CcSEcCtD
Trimethoprim—Anorexia—Dorzolamide—glaucoma	0.000477	0.00124	CcSEcCtD
Trimethoprim—Confusional state—Pilocarpine—glaucoma	0.000477	0.00124	CcSEcCtD
Trimethoprim—Decreased appetite—Acetazolamide—glaucoma	0.000474	0.00123	CcSEcCtD
Trimethoprim—Insomnia—Brimonidine—glaucoma	0.000474	0.00123	CcSEcCtD
Trimethoprim—DHFR—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—glaucoma	0.000472	0.00776	CbGpPWpGaD
Trimethoprim—Gastrointestinal disorder—Acetazolamide—glaucoma	0.000471	0.00122	CcSEcCtD
Trimethoprim—Nausea—Methazolamide—glaucoma	0.000468	0.00122	CcSEcCtD
Trimethoprim—Dyspnoea—Brimonidine—glaucoma	0.000467	0.00121	CcSEcCtD
Trimethoprim—Mental disorder—Clonidine—glaucoma	0.000465	0.00121	CcSEcCtD
Trimethoprim—Shock—Pilocarpine—glaucoma	0.000465	0.00121	CcSEcCtD
Trimethoprim—Thrombocytopenia—Pilocarpine—glaucoma	0.000463	0.0012	CcSEcCtD
Trimethoprim—Erythema—Clonidine—glaucoma	0.000462	0.0012	CcSEcCtD
Trimethoprim—Dyspepsia—Brimonidine—glaucoma	0.000461	0.0012	CcSEcCtD
Trimethoprim—Hallucination—Betaxolol—glaucoma	0.00046	0.0012	CcSEcCtD
Trimethoprim—Musculoskeletal discomfort—Dorzolamide—glaucoma	0.000456	0.00118	CcSEcCtD
Trimethoprim—Musculoskeletal discomfort—Travoprost—glaucoma	0.000454	0.00118	CcSEcCtD
Trimethoprim—Insomnia—Dorzolamide—glaucoma	0.000452	0.00118	CcSEcCtD
Trimethoprim—Gastrointestinal disorder—Brimonidine—glaucoma	0.000452	0.00117	CcSEcCtD
Trimethoprim—Anorexia—Pilocarpine—glaucoma	0.000451	0.00117	CcSEcCtD
Trimethoprim—Feeling abnormal—Acetazolamide—glaucoma	0.00045	0.00117	CcSEcCtD
Trimethoprim—Hypersensitivity—Apraclonidine—glaucoma	0.000449	0.00117	CcSEcCtD
Trimethoprim—Musculoskeletal discomfort—Brinzolamide—glaucoma	0.000448	0.00116	CcSEcCtD
Trimethoprim—Dyspnoea—Dorzolamide—glaucoma	0.000446	0.00116	CcSEcCtD
Trimethoprim—Insomnia—Brinzolamide—glaucoma	0.000445	0.00116	CcSEcCtD
Trimethoprim—Dyspnoea—Travoprost—glaucoma	0.000444	0.00115	CcSEcCtD
Trimethoprim—DHFR—Mitotic G1-G1/S phases—CCND2—glaucoma	0.000442	0.00727	CbGpPWpGaD
Trimethoprim—Dyspepsia—Dorzolamide—glaucoma	0.00044	0.00114	CcSEcCtD
Trimethoprim—Dyspnoea—Brinzolamide—glaucoma	0.000438	0.00114	CcSEcCtD
Trimethoprim—Dyspepsia—Travoprost—glaucoma	0.000438	0.00114	CcSEcCtD
Trimethoprim—Decreased appetite—Dorzolamide—glaucoma	0.000435	0.00113	CcSEcCtD
Trimethoprim—Urticaria—Acetazolamide—glaucoma	0.000434	0.00113	CcSEcCtD
Trimethoprim—Tremor—Clonidine—glaucoma	0.000433	0.00113	CcSEcCtD
Trimethoprim—Dyspepsia—Brinzolamide—glaucoma	0.000433	0.00112	CcSEcCtD
Trimethoprim—DHFR—Cell Cycle, Mitotic—FGFR1OP—glaucoma	0.000433	0.00712	CbGpPWpGaD
Trimethoprim—Eye disorder—Betaxolol—glaucoma	0.000432	0.00112	CcSEcCtD
Trimethoprim—Pruritus—Apraclonidine—glaucoma	0.000432	0.00112	CcSEcCtD
Trimethoprim—Body temperature increased—Acetazolamide—glaucoma	0.000431	0.00112	CcSEcCtD
Trimethoprim—Tinnitus—Betaxolol—glaucoma	0.000431	0.00112	CcSEcCtD
Trimethoprim—Musculoskeletal discomfort—Pilocarpine—glaucoma	0.000431	0.00112	CcSEcCtD
Trimethoprim—Gastrointestinal disorder—Travoprost—glaucoma	0.00043	0.00112	CcSEcCtD
Trimethoprim—Insomnia—Pilocarpine—glaucoma	0.000427	0.00111	CcSEcCtD
Trimethoprim—Decreased appetite—Brinzolamide—glaucoma	0.000427	0.00111	CcSEcCtD
Trimethoprim—Constipation—Travoprost—glaucoma	0.000426	0.00111	CcSEcCtD
Trimethoprim—Agitation—Clonidine—glaucoma	0.000425	0.0011	CcSEcCtD
Trimethoprim—Gastrointestinal disorder—Brinzolamide—glaucoma	0.000425	0.0011	CcSEcCtD
Trimethoprim—Angioedema—Clonidine—glaucoma	0.000423	0.0011	CcSEcCtD
Trimethoprim—Dyspnoea—Pilocarpine—glaucoma	0.000421	0.00109	CcSEcCtD
Trimethoprim—Depression—Timolol—glaucoma	0.00042	0.00109	CcSEcCtD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—PITX2—glaucoma	0.000419	0.0069	CbGpPWpGaD
Trimethoprim—Pruritus—Bimatoprost—glaucoma	0.000418	0.00109	CcSEcCtD
Trimethoprim—Immune system disorder—Betaxolol—glaucoma	0.000418	0.00109	CcSEcCtD
Trimethoprim—Diarrhoea—Apraclonidine—glaucoma	0.000417	0.00108	CcSEcCtD
Trimethoprim—Mediastinal disorder—Betaxolol—glaucoma	0.000417	0.00108	CcSEcCtD
Trimethoprim—Dyspepsia—Pilocarpine—glaucoma	0.000416	0.00108	CcSEcCtD
Trimethoprim—Syncope—Clonidine—glaucoma	0.000415	0.00108	CcSEcCtD
Trimethoprim—Feeling abnormal—Dorzolamide—glaucoma	0.000412	0.00107	CcSEcCtD
Trimethoprim—Decreased appetite—Pilocarpine—glaucoma	0.000411	0.00107	CcSEcCtD
Trimethoprim—Feeling abnormal—Travoprost—glaucoma	0.00041	0.00107	CcSEcCtD
Trimethoprim—Gastrointestinal pain—Dorzolamide—glaucoma	0.000409	0.00106	CcSEcCtD
Trimethoprim—Gastrointestinal disorder—Pilocarpine—glaucoma	0.000408	0.00106	CcSEcCtD
Trimethoprim—Gastrointestinal pain—Travoprost—glaucoma	0.000407	0.00106	CcSEcCtD
Trimethoprim—DHFR—Cell Cycle, Mitotic—RAB8A—glaucoma	0.000407	0.0067	CbGpPWpGaD
Trimethoprim—Loss of consciousness—Clonidine—glaucoma	0.000406	0.00106	CcSEcCtD
Trimethoprim—Feeling abnormal—Brinzolamide—glaucoma	0.000405	0.00105	CcSEcCtD
Trimethoprim—Mental disorder—Betaxolol—glaucoma	0.000405	0.00105	CcSEcCtD
Trimethoprim—Constipation—Pilocarpine—glaucoma	0.000404	0.00105	CcSEcCtD
Trimethoprim—Cough—Clonidine—glaucoma	0.000404	0.00105	CcSEcCtD
Trimethoprim—Dizziness—Apraclonidine—glaucoma	0.000403	0.00105	CcSEcCtD
Trimethoprim—Malnutrition—Betaxolol—glaucoma	0.000403	0.00105	CcSEcCtD
Trimethoprim—Erythema—Betaxolol—glaucoma	0.000403	0.00105	CcSEcCtD
Trimethoprim—Urticaria—Dorzolamide—glaucoma	0.000397	0.00103	CcSEcCtD
Trimethoprim—Epistaxis—Timolol—glaucoma	0.000397	0.00103	CcSEcCtD
Trimethoprim—DHFR—Mitotic G1-G1/S phases—CDKN2B—glaucoma	0.000396	0.00652	CbGpPWpGaD
Trimethoprim—Body temperature increased—Dorzolamide—glaucoma	0.000395	0.00103	CcSEcCtD
Trimethoprim—Abdominal pain—Dorzolamide—glaucoma	0.000395	0.00103	CcSEcCtD
Trimethoprim—Arthralgia—Clonidine—glaucoma	0.000394	0.00102	CcSEcCtD
Trimethoprim—Abdominal pain—Travoprost—glaucoma	0.000394	0.00102	CcSEcCtD
Trimethoprim—Agranulocytosis—Timolol—glaucoma	0.000393	0.00102	CcSEcCtD
Trimethoprim—Anxiety—Clonidine—glaucoma	0.000392	0.00102	CcSEcCtD
Trimethoprim—Dizziness—Bimatoprost—glaucoma	0.000391	0.00102	CcSEcCtD
Trimethoprim—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	0.000391	0.00102	CcSEcCtD
Trimethoprim—Urticaria—Brinzolamide—glaucoma	0.000391	0.00101	CcSEcCtD
Trimethoprim—CYP3A4—Estrogen metabolism—CYP1B1—glaucoma	0.00039	0.00643	CbGpPWpGaD
Trimethoprim—Feeling abnormal—Pilocarpine—glaucoma	0.000389	0.00101	CcSEcCtD
Trimethoprim—DHFR—Fluoropyrimidine Activity—TP53—glaucoma	0.000389	0.0064	CbGpPWpGaD
Trimethoprim—Vomiting—Apraclonidine—glaucoma	0.000388	0.00101	CcSEcCtD
Trimethoprim—DHFR—Cell Cycle—FGFR1OP—glaucoma	0.000387	0.00637	CbGpPWpGaD
Trimethoprim—Gastrointestinal pain—Pilocarpine—glaucoma	0.000386	0.001	CcSEcCtD
Trimethoprim—Hypersensitivity—Brimonidine—glaucoma	0.000386	0.001	CcSEcCtD
Trimethoprim—TYMS—Mitotic G1-G1/S phases—CCND2—glaucoma	0.000385	0.00634	CbGpPWpGaD
Trimethoprim—Dermatitis—Apraclonidine—glaucoma	0.000384	0.000998	CcSEcCtD
Trimethoprim—Headache—Apraclonidine—glaucoma	0.000382	0.000993	CcSEcCtD
Trimethoprim—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.000381	0.00627	CbGpPWpGaD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—SMO—glaucoma	0.000381	0.00627	CbGpPWpGaD
Trimethoprim—Confusional state—Clonidine—glaucoma	0.000381	0.000989	CcSEcCtD
Trimethoprim—TYMS—Cell Cycle, Mitotic—FGFR1OP—glaucoma	0.000377	0.00622	CbGpPWpGaD
Trimethoprim—Tremor—Betaxolol—glaucoma	0.000377	0.00098	CcSEcCtD
Trimethoprim—Hallucination—Timolol—glaucoma	0.000376	0.000977	CcSEcCtD
Trimethoprim—Body temperature increased—Pilocarpine—glaucoma	0.000374	0.000971	CcSEcCtD
Trimethoprim—Abdominal pain—Pilocarpine—glaucoma	0.000374	0.000971	CcSEcCtD
Trimethoprim—Diarrhoea—Acetazolamide—glaucoma	0.000373	0.00097	CcSEcCtD
Trimethoprim—Rash—Bimatoprost—glaucoma	0.000373	0.000969	CcSEcCtD
Trimethoprim—Dermatitis—Bimatoprost—glaucoma	0.000373	0.000968	CcSEcCtD
Trimethoprim—Shock—Clonidine—glaucoma	0.000371	0.000965	CcSEcCtD
Trimethoprim—Connective tissue disorder—Timolol—glaucoma	0.000371	0.000964	CcSEcCtD
Trimethoprim—Pruritus—Brimonidine—glaucoma	0.000371	0.000963	CcSEcCtD
Trimethoprim—Headache—Bimatoprost—glaucoma	0.000371	0.000963	CcSEcCtD
Trimethoprim—DHFR—E2F transcription factor network—CDKN2A—glaucoma	0.00037	0.00609	CbGpPWpGaD
Trimethoprim—Nervous system disorder—Clonidine—glaucoma	0.00037	0.000961	CcSEcCtD
Trimethoprim—Thrombocytopenia—Clonidine—glaucoma	0.00037	0.00096	CcSEcCtD
Trimethoprim—Hypersensitivity—Dorzolamide—glaucoma	0.000369	0.000957	CcSEcCtD
Trimethoprim—Hypersensitivity—Travoprost—glaucoma	0.000367	0.000953	CcSEcCtD
Trimethoprim—Skin disorder—Clonidine—glaucoma	0.000367	0.000952	CcSEcCtD
Trimethoprim—DHFR—Cell Cycle—RAB8A—glaucoma	0.000364	0.00599	CbGpPWpGaD
Trimethoprim—Nausea—Apraclonidine—glaucoma	0.000362	0.000941	CcSEcCtD
Trimethoprim—Hypersensitivity—Brinzolamide—glaucoma	0.000362	0.000941	CcSEcCtD
Trimethoprim—Vertigo—Betaxolol—glaucoma	0.000362	0.00094	CcSEcCtD
Trimethoprim—Syncope—Betaxolol—glaucoma	0.000361	0.000938	CcSEcCtD
Trimethoprim—Dizziness—Acetazolamide—glaucoma	0.000361	0.000937	CcSEcCtD
Trimethoprim—Anorexia—Clonidine—glaucoma	0.00036	0.000935	CcSEcCtD
Trimethoprim—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.000356	0.00586	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle, Mitotic—RAB8A—glaucoma	0.000355	0.00584	CbGpPWpGaD
Trimethoprim—Pruritus—Dorzolamide—glaucoma	0.000354	0.000919	CcSEcCtD
Trimethoprim—Loss of consciousness—Betaxolol—glaucoma	0.000354	0.000919	CcSEcCtD
Trimethoprim—Eye disorder—Timolol—glaucoma	0.000353	0.000917	CcSEcCtD
Trimethoprim—DHFR—Cell Cycle, Mitotic—OPTN—glaucoma	0.000353	0.00581	CbGpPWpGaD
Trimethoprim—Pruritus—Travoprost—glaucoma	0.000352	0.000915	CcSEcCtD
Trimethoprim—Tinnitus—Timolol—glaucoma	0.000352	0.000915	CcSEcCtD
Trimethoprim—Cough—Betaxolol—glaucoma	0.000351	0.000913	CcSEcCtD
Trimethoprim—Nausea—Bimatoprost—glaucoma	0.000351	0.000913	CcSEcCtD
Trimethoprim—Hypersensitivity—Pilocarpine—glaucoma	0.000348	0.000905	CcSEcCtD
Trimethoprim—Pruritus—Brinzolamide—glaucoma	0.000348	0.000904	CcSEcCtD
Trimethoprim—Vomiting—Acetazolamide—glaucoma	0.000347	0.000901	CcSEcCtD
Trimethoprim—Dizziness—Brimonidine—glaucoma	0.000346	0.0009	CcSEcCtD
Trimethoprim—TYMS—Mitotic G1-G1/S phases—CDKN2B—glaucoma	0.000345	0.00569	CbGpPWpGaD
Trimethoprim—CYP3A4—Tamoxifen metabolism—CYP1B1—glaucoma	0.000345	0.00568	CbGpPWpGaD
Trimethoprim—Musculoskeletal discomfort—Clonidine—glaucoma	0.000344	0.000893	CcSEcCtD
Trimethoprim—Myalgia—Betaxolol—glaucoma	0.000343	0.00089	CcSEcCtD
Trimethoprim—Arthralgia—Betaxolol—glaucoma	0.000343	0.00089	CcSEcCtD
Trimethoprim—Diarrhoea—Dorzolamide—glaucoma	0.000342	0.000889	CcSEcCtD
Trimethoprim—Headache—Acetazolamide—glaucoma	0.000342	0.000888	CcSEcCtD
Trimethoprim—Anxiety—Betaxolol—glaucoma	0.000342	0.000887	CcSEcCtD
Trimethoprim—Insomnia—Clonidine—glaucoma	0.000341	0.000887	CcSEcCtD
Trimethoprim—Immune system disorder—Timolol—glaucoma	0.000341	0.000887	CcSEcCtD
Trimethoprim—Diarrhoea—Travoprost—glaucoma	0.000341	0.000885	CcSEcCtD
Trimethoprim—Mediastinal disorder—Timolol—glaucoma	0.000341	0.000885	CcSEcCtD
Trimethoprim—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	0.00034	0.000884	CcSEcCtD
Trimethoprim—DHFR—Metabolism—NARFL—glaucoma	0.00034	0.0056	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—CA5A—glaucoma	0.00034	0.0056	CbGpPWpGaD
Trimethoprim—TYMS—Fluoropyrimidine Activity—TP53—glaucoma	0.000339	0.00559	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle—FGFR1OP—glaucoma	0.000338	0.00556	CbGpPWpGaD
Trimethoprim—Dyspnoea—Clonidine—glaucoma	0.000336	0.000874	CcSEcCtD
Trimethoprim—Diarrhoea—Brinzolamide—glaucoma	0.000336	0.000874	CcSEcCtD
Trimethoprim—Pruritus—Pilocarpine—glaucoma	0.000334	0.000869	CcSEcCtD
Trimethoprim—Confusional state—Betaxolol—glaucoma	0.000331	0.000861	CcSEcCtD
Trimethoprim—Mental disorder—Timolol—glaucoma	0.000331	0.00086	CcSEcCtD
Trimethoprim—Dizziness—Dorzolamide—glaucoma	0.000331	0.000859	CcSEcCtD
Trimethoprim—Rash—Brimonidine—glaucoma	0.00033	0.000858	CcSEcCtD
Trimethoprim—Dermatitis—Brimonidine—glaucoma	0.00033	0.000857	CcSEcCtD
Trimethoprim—Dizziness—Travoprost—glaucoma	0.000329	0.000855	CcSEcCtD
Trimethoprim—Malnutrition—Timolol—glaucoma	0.000329	0.000854	CcSEcCtD
Trimethoprim—Erythema—Timolol—glaucoma	0.000329	0.000854	CcSEcCtD
Trimethoprim—Headache—Brimonidine—glaucoma	0.000328	0.000852	CcSEcCtD
Trimethoprim—Decreased appetite—Clonidine—glaucoma	0.000328	0.000852	CcSEcCtD
Trimethoprim—DHFR—E2F transcription factor network—CDKN1B—glaucoma	0.000328	0.0054	CbGpPWpGaD
Trimethoprim—Gastrointestinal disorder—Clonidine—glaucoma	0.000326	0.000846	CcSEcCtD
Trimethoprim—Dizziness—Brinzolamide—glaucoma	0.000325	0.000845	CcSEcCtD
Trimethoprim—Nausea—Acetazolamide—glaucoma	0.000324	0.000842	CcSEcCtD
Trimethoprim—Diarrhoea—Pilocarpine—glaucoma	0.000323	0.00084	CcSEcCtD
Trimethoprim—Shock—Betaxolol—glaucoma	0.000323	0.00084	CcSEcCtD
Trimethoprim—TYMS—E2F transcription factor network—CDKN2A—glaucoma	0.000323	0.00532	CbGpPWpGaD
Trimethoprim—Constipation—Clonidine—glaucoma	0.000323	0.000838	CcSEcCtD
Trimethoprim—Nervous system disorder—Betaxolol—glaucoma	0.000322	0.000837	CcSEcCtD
Trimethoprim—Thrombocytopenia—Betaxolol—glaucoma	0.000322	0.000836	CcSEcCtD
Trimethoprim—CYP2C8—Arachidonic acid metabolism—CYP1B1—glaucoma	0.000321	0.00529	CbGpPWpGaD
Trimethoprim—Skin disorder—Betaxolol—glaucoma	0.000319	0.000829	CcSEcCtD
Trimethoprim—Vomiting—Dorzolamide—glaucoma	0.000318	0.000826	CcSEcCtD
Trimethoprim—TYMS—Cell Cycle—RAB8A—glaucoma	0.000317	0.00523	CbGpPWpGaD
Trimethoprim—Rash—Dorzolamide—glaucoma	0.000315	0.000819	CcSEcCtD
Trimethoprim—DHFR—Cell Cycle—OPTN—glaucoma	0.000315	0.00519	CbGpPWpGaD
Trimethoprim—Dermatitis—Dorzolamide—glaucoma	0.000315	0.000818	CcSEcCtD
Trimethoprim—Rash—Travoprost—glaucoma	0.000314	0.000816	CcSEcCtD
Trimethoprim—Dermatitis—Travoprost—glaucoma	0.000314	0.000815	CcSEcCtD
Trimethoprim—Headache—Dorzolamide—glaucoma	0.000313	0.000814	CcSEcCtD
Trimethoprim—Anorexia—Betaxolol—glaucoma	0.000313	0.000814	CcSEcCtD
Trimethoprim—Vomiting—Brinzolamide—glaucoma	0.000313	0.000812	CcSEcCtD
Trimethoprim—Dizziness—Pilocarpine—glaucoma	0.000313	0.000812	CcSEcCtD
Trimethoprim—CYP3A4—Estrogen metabolism—GSTM1—glaucoma	0.000312	0.00514	CbGpPWpGaD
Trimethoprim—Headache—Travoprost—glaucoma	0.000312	0.00081	CcSEcCtD
Trimethoprim—Nausea—Brimonidine—glaucoma	0.000311	0.000808	CcSEcCtD
Trimethoprim—Feeling abnormal—Clonidine—glaucoma	0.000311	0.000808	CcSEcCtD
Trimethoprim—Rash—Brinzolamide—glaucoma	0.00031	0.000805	CcSEcCtD
Trimethoprim—Dermatitis—Brinzolamide—glaucoma	0.00031	0.000805	CcSEcCtD
Trimethoprim—Gastrointestinal pain—Clonidine—glaucoma	0.000309	0.000802	CcSEcCtD
Trimethoprim—Headache—Brinzolamide—glaucoma	0.000308	0.0008	CcSEcCtD
Trimethoprim—DHFR—Disease—LRP12—glaucoma	0.000308	0.00507	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle, Mitotic—OPTN—glaucoma	0.000308	0.00507	CbGpPWpGaD
Trimethoprim—DHFR—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—glaucoma	0.000301	0.00495	CbGpPWpGaD
Trimethoprim—Angioedema—Timolol—glaucoma	0.000301	0.000781	CcSEcCtD
Trimethoprim—Vomiting—Pilocarpine—glaucoma	0.0003	0.000781	CcSEcCtD
Trimethoprim—Urticaria—Clonidine—glaucoma	0.0003	0.000779	CcSEcCtD
Trimethoprim—Musculoskeletal discomfort—Betaxolol—glaucoma	0.000299	0.000778	CcSEcCtD
Trimethoprim—Abdominal pain—Clonidine—glaucoma	0.000298	0.000775	CcSEcCtD
Trimethoprim—Body temperature increased—Clonidine—glaucoma	0.000298	0.000775	CcSEcCtD
Trimethoprim—Rash—Pilocarpine—glaucoma	0.000298	0.000774	CcSEcCtD
Trimethoprim—Dermatitis—Pilocarpine—glaucoma	0.000298	0.000773	CcSEcCtD
Trimethoprim—Insomnia—Betaxolol—glaucoma	0.000297	0.000772	CcSEcCtD
Trimethoprim—Nausea—Dorzolamide—glaucoma	0.000297	0.000772	CcSEcCtD
Trimethoprim—TYMS—Metabolism—CA5A—glaucoma	0.000297	0.00489	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—NARFL—glaucoma	0.000297	0.00489	CbGpPWpGaD
Trimethoprim—Headache—Pilocarpine—glaucoma	0.000296	0.000769	CcSEcCtD
Trimethoprim—Nausea—Travoprost—glaucoma	0.000296	0.000768	CcSEcCtD
Trimethoprim—Vertigo—Timolol—glaucoma	0.000296	0.000768	CcSEcCtD
Trimethoprim—Syncope—Timolol—glaucoma	0.000295	0.000766	CcSEcCtD
Trimethoprim—Dyspnoea—Betaxolol—glaucoma	0.000293	0.000761	CcSEcCtD
Trimethoprim—Nausea—Brinzolamide—glaucoma	0.000292	0.000759	CcSEcCtD
Trimethoprim—Dyspepsia—Betaxolol—glaucoma	0.000289	0.000751	CcSEcCtD
Trimethoprim—Loss of consciousness—Timolol—glaucoma	0.000289	0.000751	CcSEcCtD
Trimethoprim—Cough—Timolol—glaucoma	0.000287	0.000746	CcSEcCtD
Trimethoprim—TYMS—Circadian rythm related genes—NGFR—glaucoma	0.000287	0.00472	CbGpPWpGaD
Trimethoprim—TYMS—E2F transcription factor network—CDKN1B—glaucoma	0.000286	0.00471	CbGpPWpGaD
Trimethoprim—Decreased appetite—Betaxolol—glaucoma	0.000286	0.000742	CcSEcCtD
Trimethoprim—DHFR—Retinoblastoma (RB) in Cancer—CDKN1B—glaucoma	0.000285	0.00469	CbGpPWpGaD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	0.000284	0.00467	CbGpPWpGaD
Trimethoprim—Gastrointestinal disorder—Betaxolol—glaucoma	0.000284	0.000737	CcSEcCtD
Trimethoprim—Constipation—Betaxolol—glaucoma	0.000281	0.00073	CcSEcCtD
Trimethoprim—Nausea—Pilocarpine—glaucoma	0.000281	0.000729	CcSEcCtD
Trimethoprim—Arthralgia—Timolol—glaucoma	0.00028	0.000727	CcSEcCtD
Trimethoprim—Myalgia—Timolol—glaucoma	0.00028	0.000727	CcSEcCtD
Trimethoprim—Anxiety—Timolol—glaucoma	0.000279	0.000725	CcSEcCtD
Trimethoprim—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	0.000278	0.000722	CcSEcCtD
Trimethoprim—Hypersensitivity—Clonidine—glaucoma	0.000278	0.000722	CcSEcCtD
Trimethoprim—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.000278	0.00457	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle—OPTN—glaucoma	0.000275	0.00453	CbGpPWpGaD
Trimethoprim—CYP2C8—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.000274	0.00451	CbGpPWpGaD
Trimethoprim—TYMS—Circadian rythm related genes—NTRK1—glaucoma	0.000273	0.00449	CbGpPWpGaD
Trimethoprim—Feeling abnormal—Betaxolol—glaucoma	0.000271	0.000703	CcSEcCtD
Trimethoprim—Confusional state—Timolol—glaucoma	0.000271	0.000703	CcSEcCtD
Trimethoprim—Anaphylactic shock—Timolol—glaucoma	0.000268	0.000697	CcSEcCtD
Trimethoprim—Pruritus—Clonidine—glaucoma	0.000267	0.000694	CcSEcCtD
Trimethoprim—Shock—Timolol—glaucoma	0.000264	0.000686	CcSEcCtD
Trimethoprim—Nervous system disorder—Timolol—glaucoma	0.000263	0.000684	CcSEcCtD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	0.000262	0.00431	CbGpPWpGaD
Trimethoprim—CYP2C9—Arachidonic acid metabolism—CYP1B1—glaucoma	0.000261	0.0043	CbGpPWpGaD
Trimethoprim—Urticaria—Betaxolol—glaucoma	0.000261	0.000678	CcSEcCtD
Trimethoprim—Skin disorder—Timolol—glaucoma	0.000261	0.000677	CcSEcCtD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	0.00026	0.00428	CbGpPWpGaD
Trimethoprim—Body temperature increased—Betaxolol—glaucoma	0.00026	0.000675	CcSEcCtD
Trimethoprim—Diarrhoea—Clonidine—glaucoma	0.000258	0.000671	CcSEcCtD
Trimethoprim—Anorexia—Timolol—glaucoma	0.000256	0.000665	CcSEcCtD
Trimethoprim—DHFR—Folate Metabolism—TNF—glaucoma	0.000253	0.00417	CbGpPWpGaD
Trimethoprim—Dizziness—Clonidine—glaucoma	0.00025	0.000648	CcSEcCtD
Trimethoprim—TYMS—Retinoblastoma (RB) in Cancer—CDKN1B—glaucoma	0.000249	0.00409	CbGpPWpGaD
Trimethoprim—Musculoskeletal discomfort—Timolol—glaucoma	0.000245	0.000635	CcSEcCtD
Trimethoprim—Insomnia—Timolol—glaucoma	0.000243	0.000631	CcSEcCtD
Trimethoprim—Hypersensitivity—Betaxolol—glaucoma	0.000242	0.000629	CcSEcCtD
Trimethoprim—Vomiting—Clonidine—glaucoma	0.00024	0.000623	CcSEcCtD
Trimethoprim—Dyspnoea—Timolol—glaucoma	0.000239	0.000622	CcSEcCtD
Trimethoprim—Rash—Clonidine—glaucoma	0.000238	0.000618	CcSEcCtD
Trimethoprim—DHFR—G1/S Transition—CDKN1B—glaucoma	0.000238	0.00392	CbGpPWpGaD
Trimethoprim—Dermatitis—Clonidine—glaucoma	0.000238	0.000618	CcSEcCtD
Trimethoprim—Headache—Clonidine—glaucoma	0.000236	0.000614	CcSEcCtD
Trimethoprim—Dyspepsia—Timolol—glaucoma	0.000236	0.000614	CcSEcCtD
Trimethoprim—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.000235	0.00387	CbGpPWpGaD
Trimethoprim—Decreased appetite—Timolol—glaucoma	0.000233	0.000606	CcSEcCtD
Trimethoprim—Pruritus—Betaxolol—glaucoma	0.000232	0.000604	CcSEcCtD
Trimethoprim—Gastrointestinal disorder—Timolol—glaucoma	0.000232	0.000602	CcSEcCtD
Trimethoprim—DHFR—Mitotic G1-G1/S phases—CDKN2A—glaucoma	0.000226	0.00373	CbGpPWpGaD
Trimethoprim—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.000226	0.00372	CbGpPWpGaD
Trimethoprim—CYP2C8—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000225	0.00371	CbGpPWpGaD
Trimethoprim—Diarrhoea—Betaxolol—glaucoma	0.000225	0.000584	CcSEcCtD
Trimethoprim—Nausea—Clonidine—glaucoma	0.000224	0.000582	CcSEcCtD
Trimethoprim—DHFR—Folate Metabolism—TP53—glaucoma	0.000223	0.00368	CbGpPWpGaD
Trimethoprim—CYP2C9—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.000223	0.00367	CbGpPWpGaD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	0.000222	0.00366	CbGpPWpGaD
Trimethoprim—Feeling abnormal—Timolol—glaucoma	0.000221	0.000575	CcSEcCtD
Trimethoprim—Gastrointestinal pain—Timolol—glaucoma	0.00022	0.00057	CcSEcCtD
Trimethoprim—Dizziness—Betaxolol—glaucoma	0.000217	0.000564	CcSEcCtD
Trimethoprim—TYMS—Circadian rythm related genes—FAS—glaucoma	0.000214	0.00352	CbGpPWpGaD
Trimethoprim—Urticaria—Timolol—glaucoma	0.000213	0.000554	CcSEcCtD
Trimethoprim—Body temperature increased—Timolol—glaucoma	0.000212	0.000551	CcSEcCtD
Trimethoprim—Abdominal pain—Timolol—glaucoma	0.000212	0.000551	CcSEcCtD
Trimethoprim—Vomiting—Betaxolol—glaucoma	0.000209	0.000543	CcSEcCtD
Trimethoprim—TYMS—G1/S Transition—CDKN1B—glaucoma	0.000208	0.00342	CbGpPWpGaD
Trimethoprim—Rash—Betaxolol—glaucoma	0.000207	0.000538	CcSEcCtD
Trimethoprim—Dermatitis—Betaxolol—glaucoma	0.000207	0.000538	CcSEcCtD
Trimethoprim—Headache—Betaxolol—glaucoma	0.000206	0.000535	CcSEcCtD
Trimethoprim—DHFR—Mitotic G1-G1/S phases—CDKN1B—glaucoma	0.0002	0.0033	CbGpPWpGaD
Trimethoprim—DHFR—Disease—FGFR1OP—glaucoma	0.000198	0.00327	CbGpPWpGaD
Trimethoprim—DHFR—Disease—HEYL—glaucoma	0.000198	0.00327	CbGpPWpGaD
Trimethoprim—Hypersensitivity—Timolol—glaucoma	0.000198	0.000514	CcSEcCtD
Trimethoprim—TYMS—Mitotic G1-G1/S phases—CDKN2A—glaucoma	0.000197	0.00325	CbGpPWpGaD
Trimethoprim—Nausea—Betaxolol—glaucoma	0.000195	0.000507	CcSEcCtD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	0.00019	0.00313	CbGpPWpGaD
Trimethoprim—Pruritus—Timolol—glaucoma	0.00019	0.000493	CcSEcCtD
Trimethoprim—CYP3A4—Tryptophan metabolism—CYP1B1—glaucoma	0.000184	0.00303	CbGpPWpGaD
Trimethoprim—Diarrhoea—Timolol—glaucoma	0.000184	0.000477	CcSEcCtD
Trimethoprim—CYP2C9—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000183	0.00302	CbGpPWpGaD
Trimethoprim—ABCB1—HIF-1-alpha transcription factor network—EDN1—glaucoma	0.000181	0.00298	CbGpPWpGaD
Trimethoprim—DHFR—Retinoblastoma (RB) in Cancer—TP53—glaucoma	0.000179	0.00295	CbGpPWpGaD
Trimethoprim—Dizziness—Timolol—glaucoma	0.000178	0.000461	CcSEcCtD
Trimethoprim—TYMS—Mitotic G1-G1/S phases—CDKN1B—glaucoma	0.000175	0.00288	CbGpPWpGaD
Trimethoprim—Vomiting—Timolol—glaucoma	0.000171	0.000443	CcSEcCtD
Trimethoprim—Rash—Timolol—glaucoma	0.000169	0.00044	CcSEcCtD
Trimethoprim—Dermatitis—Timolol—glaucoma	0.000169	0.000439	CcSEcCtD
Trimethoprim—Headache—Timolol—glaucoma	0.000168	0.000437	CcSEcCtD
Trimethoprim—ABCB1—Transmembrane transport of small molecules—PEX19—glaucoma	0.000166	0.00274	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—CA1—glaucoma	0.000166	0.00274	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle, Mitotic—CCND2—glaucoma	0.000162	0.00267	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—CTSA—glaucoma	0.000161	0.00265	CbGpPWpGaD
Trimethoprim—Nausea—Timolol—glaucoma	0.000159	0.000414	CcSEcCtD
Trimethoprim—TYMS—Retinoblastoma (RB) in Cancer—TP53—glaucoma	0.000156	0.00257	CbGpPWpGaD
Trimethoprim—ABCB1—Allograft Rejection—IL1A—glaucoma	0.000156	0.00257	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—CA2—glaucoma	0.000152	0.0025	CbGpPWpGaD
Trimethoprim—CYP2C8—Biological oxidations—GSTT1—glaucoma	0.00015	0.00247	CbGpPWpGaD
Trimethoprim—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.000149	0.00245	CbGpPWpGaD
Trimethoprim—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.000147	0.00242	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle, Mitotic—CDKN2B—glaucoma	0.000145	0.00239	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—CA1—glaucoma	0.000145	0.00239	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle—CCND2—glaucoma	0.000145	0.00238	CbGpPWpGaD
Trimethoprim—CYP2C8—Arachidonic acid metabolism—PTGS2—glaucoma	0.000145	0.00238	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle, Mitotic—CCND2—glaucoma	0.000141	0.00233	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—CTSA—glaucoma	0.00014	0.00231	CbGpPWpGaD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	0.00014	0.0023	CbGpPWpGaD
Trimethoprim—ABCB1—Allograft Rejection—FAS—glaucoma	0.000139	0.00229	CbGpPWpGaD
Trimethoprim—ABCB1—Allograft Rejection—C3—glaucoma	0.000137	0.00226	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—CA2—glaucoma	0.000133	0.00218	CbGpPWpGaD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	0.000133	0.00218	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle—CDKN2B—glaucoma	0.00013	0.00214	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle, Mitotic—CDKN2B—glaucoma	0.000127	0.00209	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle—CCND2—glaucoma	0.000126	0.00208	CbGpPWpGaD
Trimethoprim—DHFR—Disease—HDAC9—glaucoma	0.000124	0.00204	CbGpPWpGaD
Trimethoprim—CYP2C9—Biological oxidations—GSTT1—glaucoma	0.000122	0.00201	CbGpPWpGaD
Trimethoprim—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—glaucoma	0.000121	0.002	CbGpPWpGaD
Trimethoprim—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000121	0.00199	CbGpPWpGaD
Trimethoprim—CYP2C8—Biological oxidations—CYP1B1—glaucoma	0.00012	0.00197	CbGpPWpGaD
Trimethoprim—CYP2C8—Metapathway biotransformation—CYP1B1—glaucoma	0.000118	0.00194	CbGpPWpGaD
Trimethoprim—CYP2C9—Arachidonic acid metabolism—PTGS2—glaucoma	0.000118	0.00194	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—glaucoma	0.000117	0.00193	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle—CDKN2B—glaucoma	0.000113	0.00186	CbGpPWpGaD
Trimethoprim—ABCB1—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.000112	0.00185	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—CTSA—glaucoma	0.000112	0.00184	CbGpPWpGaD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	0.00011	0.00181	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—TXN—glaucoma	0.000107	0.00176	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—NARFL—glaucoma	0.000105	0.00173	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—CA5A—glaucoma	0.000105	0.00173	CbGpPWpGaD
Trimethoprim—CYP2C9—Biological oxidations—CYP1B1—glaucoma	9.73e-05	0.0016	CbGpPWpGaD
Trimethoprim—CYP2C9—Metapathway biotransformation—CYP1B1—glaucoma	9.6e-05	0.00158	CbGpPWpGaD
Trimethoprim—CYP2C8—Biological oxidations—GSTM1—glaucoma	9.56e-05	0.00157	CbGpPWpGaD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	9.45e-05	0.00156	CbGpPWpGaD
Trimethoprim—CYP2C8—Metapathway biotransformation—GSTM1—glaucoma	9.43e-05	0.00155	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—TXN—glaucoma	9.34e-05	0.00154	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—NARFL—glaucoma	9.16e-05	0.00151	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—CA5A—glaucoma	9.16e-05	0.00151	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—CTSA—glaucoma	9.09e-05	0.0015	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	8.76e-05	0.00144	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—NARFL—glaucoma	8.56e-05	0.00141	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—CA5A—glaucoma	8.56e-05	0.00141	CbGpPWpGaD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	8.33e-05	0.00137	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—GSTT1—glaucoma	8.3e-05	0.00137	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle, Mitotic—CDKN2A—glaucoma	8.3e-05	0.00137	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	8.07e-05	0.00133	CbGpPWpGaD
Trimethoprim—CYP3A4—Biological oxidations—GSTT1—glaucoma	8.05e-05	0.00133	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	8.02e-05	0.00132	CbGpPWpGaD
Trimethoprim—TYMS—Circadian rythm related genes—TP53—glaucoma	7.99e-05	0.00132	CbGpPWpGaD
Trimethoprim—ABCB1—HIF-1-alpha transcription factor network—VEGFA—glaucoma	7.96e-05	0.00131	CbGpPWpGaD
Trimethoprim—CYP2C9—Biological oxidations—GSTM1—glaucoma	7.78e-05	0.00128	CbGpPWpGaD
Trimethoprim—CYP2C9—Metapathway biotransformation—GSTM1—glaucoma	7.67e-05	0.00126	CbGpPWpGaD
Trimethoprim—ABCB1—Transmembrane transport of small molecules—SLC6A13—glaucoma	7.5e-05	0.00123	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle—CDKN2A—glaucoma	7.42e-05	0.00122	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle, Mitotic—CDKN1B—glaucoma	7.35e-05	0.00121	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—GSTT1—glaucoma	7.25e-05	0.00119	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle, Mitotic—CDKN2A—glaucoma	7.24e-05	0.00119	CbGpPWpGaD
Trimethoprim—ABCB1—Allograft Rejection—VEGFA—glaucoma	6.89e-05	0.00113	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	6.86e-05	0.00113	CbGpPWpGaD
Trimethoprim—DHFR—Disease—CDKN2B—glaucoma	6.66e-05	0.0011	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—ABCA1—glaucoma	6.62e-05	0.00109	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—CYP1B1—glaucoma	6.62e-05	0.00109	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle—CDKN1B—glaucoma	6.57e-05	0.00108	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle—CDKN2A—glaucoma	6.48e-05	0.00107	CbGpPWpGaD
Trimethoprim—CYP3A4—Biological oxidations—CYP1B1—glaucoma	6.42e-05	0.00106	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle, Mitotic—CDKN1B—glaucoma	6.41e-05	0.00106	CbGpPWpGaD
Trimethoprim—CYP3A4—Metapathway biotransformation—CYP1B1—glaucoma	6.33e-05	0.00104	CbGpPWpGaD
Trimethoprim—ABCB1—Allograft Rejection—TNF—glaucoma	5.91e-05	0.000972	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	5.87e-05	0.000967	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—ABCA1—glaucoma	5.77e-05	0.000951	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—CYP1B1—glaucoma	5.77e-05	0.000951	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle—CDKN1B—glaucoma	5.74e-05	0.000944	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—NARFL—glaucoma	5.64e-05	0.000929	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—CA5A—glaucoma	5.64e-05	0.000929	CbGpPWpGaD
Trimethoprim—DHFR—Disease—MTHFR—glaucoma	5.58e-05	0.000919	CbGpPWpGaD
Trimethoprim—ABCB1—Transmembrane transport of small molecules—SLC6A1—glaucoma	5.49e-05	0.000903	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—GSTM1—glaucoma	5.29e-05	0.000871	CbGpPWpGaD
Trimethoprim—DHFR—Disease—APOE—glaucoma	5.2e-05	0.000856	CbGpPWpGaD
Trimethoprim—DHFR—Disease—CAV1—glaucoma	5.15e-05	0.000848	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—CA1—glaucoma	5.14e-05	0.000846	CbGpPWpGaD
Trimethoprim—CYP3A4—Biological oxidations—GSTM1—glaucoma	5.13e-05	0.000845	CbGpPWpGaD
Trimethoprim—CYP3A4—Metapathway biotransformation—GSTM1—glaucoma	5.06e-05	0.000833	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—CTSA—glaucoma	4.97e-05	0.000819	CbGpPWpGaD
Trimethoprim—DHFR—Disease—BAD—glaucoma	4.84e-05	0.000797	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—CA2—glaucoma	4.7e-05	0.000773	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—MTHFR—glaucoma	4.67e-05	0.00077	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—GSTM1—glaucoma	4.62e-05	0.00076	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	4.59e-05	0.000756	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	4.59e-05	0.000756	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—CA1—glaucoma	4.47e-05	0.000737	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—APOE—glaucoma	4.35e-05	0.000717	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—CTSA—glaucoma	4.33e-05	0.000714	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	4.32e-05	0.000711	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—CAV1—glaucoma	4.31e-05	0.00071	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—CA1—glaucoma	4.18e-05	0.000688	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle—TP53—glaucoma	4.13e-05	0.00068	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—CA2—glaucoma	4.09e-05	0.000674	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	4.09e-05	0.000673	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—MTHFR—glaucoma	4.08e-05	0.000672	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—CTSA—glaucoma	4.05e-05	0.000667	CbGpPWpGaD
Trimethoprim—DHFR—Disease—NOS3—glaucoma	3.89e-05	0.000641	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—CA2—glaucoma	3.82e-05	0.000629	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—APOE—glaucoma	3.8e-05	0.000625	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—CAV1—glaucoma	3.76e-05	0.000619	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	3.74e-05	0.000615	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	3.74e-05	0.000615	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle—TP53—glaucoma	3.6e-05	0.000593	CbGpPWpGaD
Trimethoprim—DHFR—Disease—PTGS2—glaucoma	3.56e-05	0.000586	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	3.4e-05	0.00056	CbGpPWpGaD
Trimethoprim—DHFR—Disease—CDKN1B—glaucoma	3.37e-05	0.000555	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—TXN—glaucoma	3.31e-05	0.000545	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—NOS3—glaucoma	3.26e-05	0.000537	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—APOE—glaucoma	3.02e-05	0.000497	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—glaucoma	2.99e-05	0.000493	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—PTGS2—glaucoma	2.98e-05	0.000491	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	2.91e-05	0.00048	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—TXN—glaucoma	2.88e-05	0.000475	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—NOS3—glaucoma	2.84e-05	0.000468	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—CA1—glaucoma	2.76e-05	0.000454	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—TXN—glaucoma	2.69e-05	0.000444	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—CTSA—glaucoma	2.67e-05	0.00044	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—PTGS2—glaucoma	2.6e-05	0.000428	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	2.57e-05	0.000423	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—GSTT1—glaucoma	2.57e-05	0.000423	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—CA2—glaucoma	2.52e-05	0.000415	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—APOE—glaucoma	2.46e-05	0.000405	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—glaucoma	2.44e-05	0.000401	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—GSTT1—glaucoma	2.24e-05	0.000368	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—GSTT1—glaucoma	2.09e-05	0.000344	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	2.07e-05	0.000341	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—ABCA1—glaucoma	2.04e-05	0.000337	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—CYP1B1—glaucoma	2.04e-05	0.000337	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—CYP1B1—glaucoma	1.78e-05	0.000293	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—ABCA1—glaucoma	1.78e-05	0.000293	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—TXN—glaucoma	1.78e-05	0.000292	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	1.68e-05	0.000277	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—ABCA1—glaucoma	1.66e-05	0.000274	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—CYP1B1—glaucoma	1.66e-05	0.000274	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—GSTM1—glaucoma	1.63e-05	0.000269	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—MTHFR—glaucoma	1.44e-05	0.000238	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—GSTM1—glaucoma	1.42e-05	0.000234	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—GSTT1—glaucoma	1.38e-05	0.000227	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—APOE—glaucoma	1.34e-05	0.000221	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—CAV1—glaucoma	1.33e-05	0.000219	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—GSTM1—glaucoma	1.33e-05	0.000219	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—MTHFR—glaucoma	1.26e-05	0.000207	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—MTHFR—glaucoma	1.18e-05	0.000194	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—APOE—glaucoma	1.17e-05	0.000193	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—CAV1—glaucoma	1.16e-05	0.000191	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—ABCA1—glaucoma	1.1e-05	0.000181	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—CYP1B1—glaucoma	1.1e-05	0.000181	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—APOE—glaucoma	1.09e-05	0.00018	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—CAV1—glaucoma	1.08e-05	0.000179	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—NOS3—glaucoma	1.01e-05	0.000166	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—PTGS2—glaucoma	9.21e-06	0.000152	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—NOS3—glaucoma	8.78e-06	0.000145	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—GSTM1—glaucoma	8.77e-06	0.000144	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—NOS3—glaucoma	8.2e-06	0.000135	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—PTGS2—glaucoma	8.03e-06	0.000132	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—MTHFR—glaucoma	7.75e-06	0.000128	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—PTGS2—glaucoma	7.5e-06	0.000123	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—APOE—glaucoma	7.22e-06	0.000119	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—CAV1—glaucoma	7.15e-06	0.000118	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—NOS3—glaucoma	5.41e-06	8.9e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—PTGS2—glaucoma	4.95e-06	8.14e-05	CbGpPWpGaD
